Cardiovascular disease (CVD) is increasing rapidly worldwide, especially in developing countries[@b1]. In China, CVD is now one of the leading causes of death[@b2]. CVD tends to develop about 10 years later in women than in men, with a marked increase after menopause, regardless the age at which menopause occurs[@b3]. The most important hormonal change after menopause is the decrease of estrogen[@b4], which could influence the risk of CVD through lipid and carbohydrate metabolism, coagulation parameters, blood pressure and so on[@b5].

Premature menopause has been associated with elevated CVD risk[@b6]. Observational studies show that Post-MW using hormone replacement therapy (HRT) has a greatly reduced risk of CVD[@b7]. However, some large clinical randomized controlled trials found that HRT failed to decrease the risk of CVD[@b8]. Studies that explored the role of surrogate measures of endogenous estrogen, such as parity[@b9][@b10] and age at menarche[@b11][@b12], on risk of CVD also provided conflicting conclusion. Interpretations of these conflicting studies are complicated by varying control for ethnicity, socioeconomic status (SES), lifestyle, and other potentially confounding factors.

Hypertension, type 2 diabetes mellitus (hereafter referred to as diabetes mellitus, DM), and long heart-rate-corrected QT (QTc) interval (LQTc)[@b13] are the established cardiovascular risk factors (CRFs) and associated with increased CVD morbidity and mortality. However, limited studies have comprehensively examined the long-term effects of reproductive history on these CRFs in Chinese women after menopause. In this paper, we took advantage of the China Chaoshan Biobank Cohort Study to examine the relationship between female reproductive factors (FRFs) and hypertension, DM, and LQTc in Post-MW. Age at menarche and menopause, parity, way of menopause, and menstrual cycle length, bleeding duration in reproductive age are the major components of FRFs in our study.

Results
=======

A total of 8046 Post-MW (natural menopause 7480, 93%; surgical menopause 566, 7%) were included in this study. Baseline characteristics of subjects are shown in [Table 1](#t1){ref-type="table"}. The overall prevalence of hypertension, DM, and LQTc among Post-MW of south China were 54.59%, 19.37%, and 9.26%, respectively, and it increased with age ([Table 2](#t2){ref-type="table"}).

Association of FRFs with hypertension, DM, and LQTc
---------------------------------------------------

After adjusting for SES and family history of hypertension and DM, multi-party was positive associated with hypertension, DM, and LQTc. Compared with women with 0 or 1 live birth, increasing risk of hypertension (OR, 1.51; 95% CI, 1.16--1.96), DM (OR, 1.65; 95% CI, 1.22--2.22), and LQTc (OR, 1.45; 95% CI, 1.01--2.09) were observed in women who had five or more live births. Other FRFs had no association with hypertension, DM, and LQTc (see [Supplementary Table S1](#S1){ref-type="supplementary-material"}).

In model 2, we additionally adjusted for personal hobbies and dietary habits, and found the associations between parity and hypertension, LQTc was attenuated and no longer statistically significant. Often eating meat (OR, 1.29; 95% CI, 1.07--1.57) were positive associated with hypertension, while often eating fish (OR, 0.79; 95% CI, 0.64--0.96) decreased the risk of hypertension. Tea (OR, 1.48; 95% CI, 1.07--2.05) and alcohol (OR, 0.12; 95% CI, 0.02--0.91) consumption was positive and inversely associated with increased LQTc. Multi-party was still positively associated with DM (*P* = 0.001). Often eating meat (OR, 1.34; 95% CI, 1.09--1.65) also increased the risk of DM. Smoking had no association with hypertension, DM, and LQTc (see [Supplementary Table S2](#S1){ref-type="supplementary-material"}).

In model 3, we further adjusted body mass index (BMI), waist circumference (WC), blood lipids, and uric acid (UA) on the basis of model 2. In this model, the association between parity and DM was attenuated and no longer statistically significant. Higher BMI, WC, total cholesterol (TC), triglycerides (TG), and UA were positive associated with hypertension. Higher WC, TG, and lower high-density lipoprotein cholesterol (HDL-C) were positive associated with DM (see [Supplementary Table S3](#S1){ref-type="supplementary-material"}).

[Table 3](#t3){ref-type="table"} provides a summary of the results of logistic regression analysis (here we just listed the associations between parity and hypertension, DM, and LQTc, for other FRFs had no association with these CRFs). Decreasing trends of the association between parity and hypertension (model 1: *P* = 0.004, model 2: *P* = 0.060, and model 3: *P* = 0.196), DM (model 1: *P* \< 0.0001, model 2: *P* = 0.001, and model 3: *P* = 0.057), and LQTc (model 1: *P* = 0.047, model 2: *P* = 0.067, and model 3: *P* = 0.075) were shown from model 1 to model 3.

Association of parity with hypertension, DM, and LQTc
-----------------------------------------------------

For other FRFs had no association with hypertension, DM, and LQTc, in this section, we just analyzed the association of parity with hypertension, DM, LQTc, and related risk factors. Women with more live births were older at enrollment and had later age at menarche and higher percentage of natural menopause (all *P* \< 0.0001) than those with fewer live births ([Table 4](#t4){ref-type="table"}). Though women with more live births had lower percentage of family history of hypertension and DM, they still had higher prevalence of hypertension and DM (all *P* \< 0.0001). The prevalence of LQTc also increased with parity (*P* \< 0.0001). As for personal hobbies, multi-parity women were more likely to smoke (*P* \< 0.0001) and drink (*P* = 0.021), but consumed less tea (*P* \< 0.0001). Regarding dietary habits, multi-parity women were inclined to eat more salty food and animal fat, but less meat, vegetable, fish, and plant oil (all *P* \< 0.0001).

General linear regression ([Table 5](#t5){ref-type="table"}) showed that parity were positively associated with BMI (*P* \< 0.0001), WC (*P* \< 0.0001), systolic blood pressure (SBP, *P* \< 0.0001), diastolic blood pressure (DBP, *P* \< 0.0001), fasting blood glucose (FBG, *P* \< 0.0001), low-density lipoprotein cholesterol (LDL-C, *P* \< 0.0001), TG (*P* \< 0.05), and QTc (*P* = 0.041), and inversely associated with TC (*P* \< 0.0001), HDL-C (*P* \< 0.05), and UA (*P* \< 0.05), after adjustment for confounders.

Discussion
==========

Using data from the China Chaoshan Biobank Cohort Study, we observed that the prevalence of hypertension (54.59%) and DM (19.37%) in this Post-MW was higher than that reported for women in other regions of China[@b14][@b15]. The most possible reason is that the participants in this study were older than those in other studies.

Menarche and menopause are two landmarks in a woman's reproductive life. Age at menarche and menopause has been showed associated with cardiovascular risk[@b16][@b17][@b18]. In our study, after adjusting for SES and other FRFs, age at menarche and menopause had no association with hypertension, DM, and LQTc. Study conduct in Fujian[@b19] of China also showed that no significant associations were found between age at menarche and menopause with diabetes. UK Biobank Study[@b20] demonstrated that being multiple birth and premature menarche are associated with premature menopause. We found that parity was positively and negatively correlated with age at menarche and menopause respectively. The effect of age at menarche or menopause on cardiovascular risk may be affected by other factors.

Post-MW with a history of irregular menstrual cycle has been reported had more indications of CVD and were more at risk of suffering cardiovascular events and death[@b21]. But the association between menstrual irregularity and CRFs in our study is not significant. The possible explanation may be that our cohort recruited general Post-MW and irregular cycles are not very common and severity among them.

Compared with natural menopause women, that with surgical menopause at same ages has greater risk of CVD[@b6]. Women with surgical menopause in our cohort account for 7.0%, and way of menopause (natural or surgical) have no association with CRFs. Our results inconsistent with previous study probably because that surgical menopause woman only account for a small amount of the study population and had little effect on the results. Further studies of large population or case-control design are warranted.

Repeated pregnancies and deliveries may aggravate the strain to cardiovascular system in women with multi-parity[@b22]. Study conducted in Hubei[@b23] and Guangzhou[@b24] of China showed that multi-parity was associated with increasing risk of metabolic syndrome (MetS). In the present study, multi-parity was associated with increased risk of hypertension and DM. But after further adjusting for dietary habits, WC, BMI, blood lipid, and UA, the association between parity and CRFs was eliminated, suggesting these associations was mediate in part by biological changes and lifestyle factors. The average pregnancy weight gain (17.1 ± 4.9 kg) among Chinese women[@b25] was much higher than the recommended[@b26]. Our study also showed that BMI and WC increased with parity. Body composition indices (WC or BMI) had been discovered to predict MetS in Chinese Post-MW[@b27].

Whole plant foods diet is associated with decreased menopausal symptoms in Post-MW with hypertension[@b28]. Our study showed that women with 5 or more live births usually eat less meat, vegetable, fish, and plant oil, but more salty food and animal fat than women with fewer live births. Dietary and lifestyle influence the onset of menopause and reproductive span[@b29]. Healthful eating choices play a protective role in reducing the risk of developing diabetes in Post-MW[@b30]. Halland *et al*. also suggests that higher cardiovascular mortality associated with multi-parity is caused by accumulation of negative lifestyle factors[@b31].

Ventricular arrhythmias are the main cause of sudden cardiac death[@b32]. An important cause of ventricular arrhythmia is prolongation of ventricular repolarization, which is reflected by a longer QT interval on electrocardiogram[@b33]. The prevalence of LQTc and mean QTc increased with parity in the present study. Further analysis adjusting for alcohol and tea consumption found that the association between parity and LQTc was attenuated. Alcohol consumption inversely associated with increased risk of LQTc, consistent with previous studies in the West showing that moderate alcohol use is associated with a lower risk of CVD[@b34]. Increased tea consumption has been found with a reduced risk of cardiovascular outcomes and total mortality[@b35]. Epigallocatechin-3-gallate (EGCG), major catechin of green tea, could slightly shorten the QT interval in animal model[@b36]. However, tea consumption was positive associated with increased risk of LQTc in our study. This is probably because first, the difference between animal and human heart; second, oolong tea is the most widely consumed tea in our study population, which different from green and black tea[@b37].

The strengths of this study are the large population-based material of Post-MW. Although previous studies on FRFs mostly focused on menopause, menarche or parity, we tried to balance that inadequacy by adding menstrual cycle characteristics, way of menopause and analyzed the aforementioned synthetically. We also included careful control of abundant potential confounders in multivariate models to reduce residual confounding, which may not have been considered adequately in previous studies. Previous research on QT interval mainly focused on men, women of reproductive age or animal model, our study first analyzed LQTc in Post-MW.

There are also some limitations to our study. First, information on FRFs was self-reported and therefore misclassification is inevitable. This would tend to attenuate the observed relation between FRFs and CRFs. Second, because of the differences of regions and cultures, the results of our study cannot be automatically generalized to other population.

In summary, our study suggested that multi-parity is associated with increased risk of hypertension, DM, and LQTc. Lifestyle and dyslipidemia may play an important role in the association. Thus, prevention of CRFs in Post-MW should rely on fitness, health dietary, and treatment of hyperlipidaemia. Further studies that include more comprehensive confounders are needed to explore the unclear mechanism underlying the link between FRFs and CRFs or CVD.

Methods
=======

China Chaoshan Biobank Cohort Study
-----------------------------------

The China Chaoshan Biobank Cohort Study is a large ongoing prospective, community-based study designed to investigate the prevalence of chronic non-communicable diseases and its related risk factors in south China. The study initiated in 2012 by the First Affiliated Hospital of Shantou University Medical College. Ethics approval was obtained from the Ethics Committee of the First Affiliated Hospital of Shantou University Medical College. All methods were performed in accordance with the community monitoring guidelines and regulations of the First Affiliated Hospital of Shantou University Medical College.

All participants gave informed consent prior to the study. As of December 2015, a total of 22303 participants were included in the present cohort. 8046 Post-MW from the cohort was included for the present analysis. Women who received HRT, were pregnant, had malignant tumors, or mental disorders were excluded from the study.

Assessment of hypertension, DM, and LQTc
----------------------------------------

Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg, and/or diastolic blood pressure (DBP) ≥90 mmHg, and/or use of antihypertensive medications[@b38]. Type 2 diabetes mellitus was defined as fasting blood glucose (FBG) ≥7 mmol/L (126 mg/dL) and/or being on treatment for diabetes[@b39].

Resting heart rates and QT intervals were obtained from the electrocardiograms (ECGs). QT corrected for the length of the previous cycle (QTc) was obtained using Bazett's formulae[@b40]. QTc ≥460 ms was defined as abnormally prolonged.

Assessment of female reproductive factors
-----------------------------------------

Postmenopausal was defined as lack of menstrual bleeding for at least 12 months or a history of hysterectomy and oophorectomy[@b41]. Age at menarche and menopause was retrospectively assigned as the self-reported age at the first and last menstrual period. Menstrual cycle length in reproductive age was referred as the number of days from the start of one bleeding period through the day before the start of the next menses. Bleeding duration in reproductive age was referred as the number of days from the start of one menstrual bleeding period through the last day of bleeding. The number of live births was referred to as parity in this paper. The ways of menopause include natural and surgical ways.

Assessment of covariates
------------------------

Standing height, weight, WC, TC, LDL-C, HDL-C, TG, and UA were obtained from the medical examination. BMI was defined as weight (kg)/height^2^ (m^2^). BMI and WC were divided into three groups according to the guidelines for prevention and control of overweight and obesity in Chinese adults[@b42].

Age at enrollment, marital status, occupational type, highest educational attainment, personal and family medical history (including hypertension and diabetes), FRFs, personal hobbies (smoking, alcohol and tea consumption), and dietary habits were collected via questionnaire-based interview. Family medical history included diseases in first-degree relatives including parents, offspring, and siblings. Dietary habits include the eating frequency (sometimes and often) of meat, viscus, vegetable, fish, salty food, plant oil, and animal fat. Current smoking was defined as smoking at least once a day over a period of more than half a year. Current alcohol and tea consumption was defined as drinking alcohol or tea once a week for a period of more than half a year.

Statistical analysis
--------------------

All statistical analyses were performed in SPSS 19.0 (IBM Corp© 2010) and the probability level accepted for significance was *P* \< 0.05.

Logistic regressions were used to examine the associations between FRFs and hypertension, DM, and LQTc. Results are presented as odds ratios (ORs) with 95% confidence intervals (CIs).

The differences among subjects in different groups were detected using the Kruskal-Wallis test for continuous variables and the *χ*^2^ test for categorical variables. A post hoc test using Bonferroni correction was applied, given that the overall test was significant (*P* \< 0.05). Continuous variables were summarized by medians with interquartile ranges (IQRs) (the range between the 25th and 75th percentile). Categorical variables were expressed by percentages.

General linear regression models were created to examine the association of continuous parity (exposure) with each measure of cardiovascular risk factors (outcome variables). Results are presented as least square means (LSMs) with 95% CIs and *P* values comparing differences across parity were obtained from the models.
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###### Baseline characteristics of study participants.

  Characteristics                  No. of survey (%)               Characteristics              No. of survey (%)      Characteristics   No. of survey (%)
  --------------------------- ---------------------------- -------------------------------- ------------------------- ----------------- -------------------
  Parity, live births                    61--70                      3084 (38.3)                      Meat                              
  0--1 (Ref.)                          876 (10.9)                        ≥71                       1321 (16.4)            Sometimes         5174 (64.3)
  2                                   1595 (19.8)                 Occupational type                   Often              2846 (35.4)    
  3                                   2227 (27.7)                       Manual                     1075 (13.4)             Missing           26 (0.3)
  4                                   1550 (19.3)                       Mental                      387 (4.8)              Viscus       
  ≥5                                  1798 (22.3)                Housework/retirement              6505 (80.8)            Sometimes         7343 (91.3)
  Age at menarche, y                     Other                         66 (0.8)                       Often               693 (8.6)     
  ≤14                                 1097 (13.6)                      Missing                      13 (0.2)               Missing           10 (0.1)
  15                                  1302 (16.2)                   Marital status                  Vegetable                           
  16 (Ref.)                           1404 (17.4)                      Married                     6883 (85.5)            Sometimes         2897 (36.0)
  17                                  1402 (17.4)                  Widowed/divorced                1126 (14.0)              Often           5129 (63.8)
  18                                  1275 (15.8)                      Missing                      37 (0.5)               Missing           20 (0.2)
  ≥19                                 1511 (18.8)           Highest educational attainment            Fish                              
  Missing                               55 (0.7)                      No formal                    3410 (42.4)            Sometimes         4897 (60.9)
  Age at menopause, y                Primary school                  2883 (35.8)                      Often              3094 (38.5)    
  ≤47                                 1458 (18.1)                 Junior high school                703 (8.7)              Missing           55 (0.7)
  48--49                              1541 (19.2)                Senior middle school               730 (9.1)            Salty food     
  50 (Ref.)                           1351 (16.8)                  College or above                 308 (3.8)             Sometimes         5220 (64.9)
  51--52                              1581 (19.6)                      Missing                      12 (0.1)                Often           2786 (34.6)
  53--54                              1109 (13.8)           Family history of hypertension           Missing              40 (0.5)      
  ≥55                                  957 (11.9)                         No                       6634 (82.5)            Plant oil     
  Missing                               48 (0.6)                         Yes                       1412 (17.5)            Sometimes         4081 (50.7)
  Menstrual cycle length, d    Family history of diabetes               Often                      3932 (48.9)                          
  ≤27                                  300 (3.7)                          No                       7490 (93.1)             Missing           33 (0.4)
  28--30 (Ref.)                       2189 (27.2)                        Yes                        556 (6.9)            Animal fat     
  ≥31                                 5518 (68.6)                      Smoking                      Sometimes            6159 (76.5)    
  Missing                               39 (0.5)                         Non                       7429 (92.3)              Often           1868 (23.2)
  Bleeding duration, d                  Current                       587 (7.3)                      Missing              19 (0.3)      
  ≤3                                  1528 (19.0)                      Missing                      30 (0.4)            BMI, kg/m^2^    
  4--6 (Ref.)                         4932 (61.3)                Alcohol consumption                  \<24               3718 (46.2)    
  ≥7                                  1556 (19.3)                        Non                       7825 (97.3)             24--27           3117 (38.7)
  Missing                               30 (0.4)                       Current                      183 (2.3)                ≥28            1165 (14.5)
  Way of menopause                      Missing                        38 (0.5)                      Missing              46 (0.6)      
  Natural                             7480 (93.0)                  Tea consumption           Waist circumference, cm                    
  Surgical                             566 (7.0)                         Non                       1855 (23.1)              \<80            2616 (32.5)
  Age at enrollment, y                  Current                      6163 (76.6)                     80--89               3222 (40)     
  ≤50                                  454 (5.6)                       Missing                      28 (0.3)                 ≥90            2155 (26.8)
  51--60                              3184 (39.6)                                                                          Missing           53 (0.7)

Abbreviations: y, years; d, days; BMI, body mass index.

###### The prevalence of hypertension, DM, and LQTc in post-menopausal women of China (%).

  Age at enrollment    Hypertension       DM          LQTc
  ------------------- -------------- ------------ -------------
  ≤50                     33.41         10.35         4.76
  51--60                 44.73\*       16.05\*       8.19\*
  61--70                60.31\*^†^    22.24\*^†^     9.42 \*
  ≥71                  72.30\*^†‡^    23.77\*^†^   13.02\*^†‡^
  Total                   54.59         19.37         9.26
  *P* for trend          \<0.0001      \<0.0001     \<0.0001

\*Compared with age ≤ 50, P \< 0.05. ^†^Compared with age 51--60, P \< 0.05. ^‡^Compared with age 61--70, P \< 0.05. Trend test was examined by χ^2^ test (Linear-by-Linear Association). Abbreviations: DM, type 2 diabetes mellitus; LQTc, long heart-rate-corrected QT interval. Difference between age groups was examined by χ^2^ test.

###### Odds ratios (95% confidence intervals) of hypertension, DM, and LQTc according to parity categories in different logistic regression models.

  Models          0--1 (Ref.)           2                   3                   4                  ≥5           *P* value
  -------------- ------------- ------------------- ------------------- ------------------- ------------------- -----------
  Hypertension                                                                                                 
   Model 1           1.00       1.20 (0.98, 1.48)   1.40 (1.13, 1.75)   1.55 (1.22, 1.95)   1.51 (1.16, 1.96)     0.004
   Model 2           1.00       1.06 (0.81, 1.38)   1.20 (0.91, 1.58)   1.39 (1.04, 1.87)   1.46 (1.06, 2.02)     0.060
   Model 3           1.00       0.94 (0.69, 1.27)   1.01 (0.73, 1.39)   1.21 (0.86, 1.70)   1.29 (0.89, 1.89)     0.196
  DM                                                                                                           
   Model 1           1.00       1.28 (1.00, 1.64)   1.70 (1.32, 2.20)   1.49 (1.13, 1.95)   1.65 (1.22, 2.22)   \<0.0001
   Model 2           1.00       1.26 (0.92, 1.74)   1.68 (1.21, 2.34)   1.47 (1.04, 2.07)   1.58 (1.09, 2.29)     0.001
   Model 3           1.00       1.17 (0.82, 1.67)   1.55 (1.08, 2.24)   1.35 (0.92, 1.98)   1.33 (0.88, 2.03)     0.057
  LQTc                                                                                                         
   Model 1           1.00       1.15 (0.85, 1.55)   1.19 (0.87, 1.64)   1.25 (0.87, 1.81)   1.45 (1.01, 2.09)     0.047
   Model 2           1.00       1.28 (0.86, 1.89)   1.39 (0.92, 2.09)   1.57 (0.99, 2.49)   1.53 (0.96, 2.44)     0.067
   Model 3           1.00       1.22 (0.75, 1.97)   1.23 (0.74, 2.04)   1.74 (1.01, 2.98)   1.54 (0.89, 2.66)     0.075

Model 1: age at menarche, age at menopause, cycle length, bleeding duration, way of menopause, age at enrollment, marital status, occupational type, highest educational attainment, family history of hypertension, family history of diabetes; Model 2: model 1 + smoking, alcohol consumption, tea consumption, meat, viscus, vegetable, fish, salty food, plant oil, animal fat; Model 3: model 2 + BMI, WC, TC, TG, UA, LDL-C, HDL-C. Abbreviations: DM, type 2 diabetes mellitus; LQTc, long heart-rate-corrected QT interval.

###### The differences among subjects by parity (live births).

               Variables                        0--1                  2                3                   4                   ≥5               *P* value      
  ----------------------------------- ------------------------ --------------- ------------------ ------------------- -------------------- ------------------- ----------
       Age at enrollment, y^\#^             58 (54, 62)         60 (55, 64)\*   62 (58, 66)\*^†^   63 (58, 69)\*^†‡^   68 (57, 77)\*^†‡§^       \<0.0001       
                 FRFs                  Age at menarche, y^\#^    15 (14, 16)     16 (15, 18)\*     17 (15, 18)\*^†^    17 (16, 18)\*^†‡^    17 (16, 18)\*^†‡^   \<0.0001
        Age at menopause, y^\#^             50 (48, 53)          50 (48, 53)      50 (48, 53)      50 (48, 52)\*^†‡^   50 (47, 52)\*^†‡^          0.010        
              MCL, d^\#^                    30 (30, 30)         30 (28, 30)\*    30 (28, 30)\*       30 (28, 30)\*       30 (28, 30)\*          \<0.0001       
       Bleeding duration, d^\#^               5 (4, 7)           5 (4, 6)\*      5 (4, 6)\*^†^       5 (4, 6)\*^†^       5 (4, 6)\*^†^          \<0.0001       
       Natural menopause, %\*\*                87.56               90.72\*         93.53\*^†^         94.52\*^†^          95.74\*^†‡^           \<0.0001       
           Hypertension\*\*                Prevalence, %            39.49           49.02\*           55.57\*^†^          59.28\*^†^‡          62.25\*^†‡^      \<0.0001
           Family history, %                   37.67               21.38\*         14.68\*^†^         14.58\*^†^          9.54\*^†‡§^           \<0.0001       
                DM\*\*                     Prevalence, %            9.59            14.67\*           22.00\*^†^           19.74\*^†^         25.59\*^†‡§^      \<0.0001
           Family history, %                   18.84               8.28\*          4.98\*^†^           4.71\*^†^           3.82\*^†^            \<0.0001       
              LQTc, %\*\*                       3.46               7.04\*          9.65\*^†^           9.68\*^†^          12.76\*^†‡§^          \<0.0001       
         Personal Hobbies\*\*                Smoking, %             1.73             4.08\*            7.74\*^†^           9.58\*^†^           11.01\*^†‡^      \<0.0001
        Alcohol consumption, %                  1.27                1.76              2.34               2.20              3.26\*^†^              0.021        
          Tea consumption, %                   84.66               79.30\*         76.46\*^†^         75.28\*^†^          72.58\*^†‡^           \<0.0001       
   Dietary habits (often eating)\*\*          Meat, %               36.45            37.37               37.95               36.15             27.18^†‡§^       \<0.0001
               Viscus, %                        7.94                7.51              8.11               9.35              10.77^†‡^              0.065        
             Vegetable, %                      62.36                66.37           66.56\*              64.66            53.49\*^†‡§^          \<0.0001       
                Fish, %                        37.11                38.58           41.55\*              41.26            30.52\*^†‡§^          \<0.0001       
             Salty food, %                     14.25               30.40\*         37.95\*^†^         38.99\*^†^          43.41\*^†‡§^          \<0.0001       
             Plant oil, %                      84.01               61.19\*         43.98\*^†^         39.51\*^†‡^         32.60\*^†‡§^          \<0.0001       
             Animal fat, %                      8.05               19.70\*         26.99\*^†^         25.88\*^†^           26.33\*^†^           \<0.0001       

^\#^Continuous data are presented as median and interquartile range (IQR) and were examined by the Kruskal-Wallis test. \*\*Categorical data are presented as percentage (%) and were examined by χ^2^ test. \*Compared with 0--1 live birth, *P* \< 0.05. ^†^Compared with 2 live births, *P* \< 0.05; ^‡^compared with 3 live births, *P* \< 0.05; ^§^compared with 4 live births, *P* \< 0.05; Abbreviations: y, years; d, days; MCL, menstrual cycle length; DM, type 2 diabetes mellitus; LQTc, long heart-rate-corrected QT interval.

###### Least squares means (95% confidence intervals) of cardiovascular risk factors according to parity categories in different general linear regression models.

     Variables           Model               0--1                  2                   3                   4                  ≥5           *P* value
  --------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- -----------
   BMI, kg/m^2^         Model 1        23.6 (23.3, 23.8)   24.2 (24.0, 24.3)   24.7 (24.5, 24.8)   24.7 (24.5, 24.9)   25.0 (24.7, 25.2)   \<0.0001
      Model 2      23.4 (23.1, 23.6)   24.2 (24.0, 24.4)   24.8 (24.6, 24.9)   24.9 (24.7, 25.1)   25.1 (24.8, 25.4)       \<0.0001       
      WC, cm            Model 1           81 (80, 81)         82 (82, 83)         85 (84, 85)         84 (84, 85)         85 (84, 86)      \<0.0001
      Model 2         80 (79, 81)         82 (81, 82)         85 (84, 85)         85 (84, 85)         85 (84, 86)          \<0.0001       
    SBP, mm Hg          Model 1         131 (129, 132)      135 (134, 136)      137 (136, 138)      137 (136, 138)      138 (136, 139)     \<0.0001
      Model 2       130 (128, 132)      134 (133, 135)      136 (135, 137)      136 (135, 137)      138 (136, 139)         \<0.0001       
    DBP, mm Hg          Model 1           80 (79, 81)         83 (83, 84)         85 (84, 85)         85 (84, 85)         84 (84, 85)      \<0.0001
      Model 2         80 (79, 81)         83 (83, 84)         85 (84, 85)         84 (84, 85)         85 (84, 85)          \<0.0001       
    FBG, mmol/L         Model 1        5.51 (5.36, 5.67)   5.94 (5.83, 6.05)   6.20 (6.11, 6.29)   6.02 (5.91, 6.13)   6.32 (6.18, 6.47)   \<0.0001
      Model 2      5.51 (5.34, 5.68)   5.91 (5.79, 6.02)   6.19 (6.09, 6.29)   5.99 (5.87, 6.11)   6.36 (6.18, 6.53)       \<0.0001       
    TC, mmol/L          Model 1        6.18 (6.09, 6.26)   5.99 (5.92, 6.05)   5.95 (5.90, 6.00)   5.92 (5.86, 5.98)   5.84 (5.76, 5.93)   \<0.0001
      Model 2      6.16 (6.07, 6.26)   5.97 (5.90, 6.03)   5.95 (5.89, 6.00)   5.91 (5.85, 5.98)   5.84 (5.75, 5.94)       \<0.0001       
   HDL-C, mmol/L        Model 1        1.41 (1.39, 1.43)   1.43 (1.41, 1.44)   1.40 (1.39, 1.42)   1.41 (1.39, 1.43)   1.38 (1.36, 1.40)     0.018
      Model 2      1.41 (1.39, 1.44)   1.43 (1.41, 1.44)   1.40 (1.39, 1.42)   1.41 (1.39, 1.42)   1.38 (1.35, 1.40)         0.020        
   LDL-C, mmol/L        Model 1        2.79 (2.72, 2.86)   3.37 (3.32, 3.42)   3.66 (3.61, 3.71)   3.65 (3.59, 3.70)   3.72 (3.65, 3.79)   \<0.0001
      Model 2      2.77 (2.70, 2.85)   3.35 (3.29, 3.40)   3.65 (3.60, 3.70)   3.64 (3.58, 3.70)   3.69 (3.61, 3.77)       \<0.0001       
    TG, mmol/L          Model 1        1.57 (1.46, 1.69)   1.83 (1.75, 1.91)   1.80 (1.73, 1.86)   1.76 (1.67, 1.84)   1.88 (1.78, 1.99)     0.002
      Model 2      1.61 (1.49, 1.73)   1.81 (1.73, 1.90)   1.78 (1.71, 1.86)   1.74 (1.65, 1.83)   1.90 (1.78, 2.03)         0.020        
    UA, μmol/L          Model 1         336 (329, 343)      322 (317, 327)      320 (316, 324)      311 (306, 316)      313 (306, 319)     \<0.0001
      Model 2       331 (323, 338)      320 (315, 326)      319 (315, 324)      314 (308, 319)      313 (305, 321)           0.015        
      QTc, ms           Model 1         416 (413, 419)     416\. (414, 418)     418 (416, 419)      418 (416, 420)      421 (419, 424)       0.041
      Model 2       416 (413, 419)      416 (414, 418)      417 (415, 418)      419 (417, 421)      421 (418, 424)           0.122        

Model 1: age at enrollment; Model 2: model 1 + age at menarche, age at menopause, menstrual cycle length and bleeding duration. *P* values were reported for parity as a linear variable (ordinal scale: 1 as group of 0−1; 2 as group of 2; 3 as group of 3; 4 as group of 4; and 5 as group of ≥5). Abbreviations: BMI, body mass index; WC, Waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; UA, uric acid; QTc, heart-rate-corrected QT interval.
